International Journal of Hematology

, Volume 92, Issue 3, pp 524–526

Thiamine-responsive megaloblastic anemia syndrome

  • Ali Bay
  • Mehmet Keskin
  • Samil Hizli
  • Hatice Uygun
  • Alper Dai
  • Fatma Gumruk
Case Report


Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein. The onset of disease is usually seen during infancy or at early childhood and most of the TRMA patients are originated from consanguineous families. In this case, we report a 5-month-old boy who had diagnosis of TRMA during evaluations for his anemia and thrombocytopenia. The diagnosis of TRMA should be kept in mind in differential diagnosis of megaloblastic anemia especially in the populations where the consanguinity is frequent.


Thiamine-responsive megaloblastic anemia Thrombocytopenia Diabetes mellitus 


  1. 1.
    Villa V, Rivellese A, Di Salle F, Iovine C, Poggi V, Capaldo B. Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome. J Clin Endocrinol Metab. 2000;85:947–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Lorber A, Gazit AZ, Khoury A, Schwartz Y, Mandel H. Cardiac manifestations in thiamine responsive megaloblastic anemia syndrome. Pediatr Cardiol. 2003;24:476–81.CrossRefPubMedGoogle Scholar
  3. 3.
    Ozdemir MA, Akcakus M, Kurtoglu S, Gunes T, Torun YA. TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature. Pediatric Diabetes. 2002;3:205–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Laforenza U, Patrini C, Alvisi C, Faelli A, Licandro A, Rindi G. Thiamine uptake in human intestinal biopsy specimens, including observations from a patient with acute thiamine deficiency. Am J Clin Nutr. 1997;66:320–6.PubMedGoogle Scholar
  5. 5.
    Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet. 1999;22:309–12.CrossRefPubMedGoogle Scholar
  6. 6.
    Ricketts CJ, Minton JA, Samuel J, et al. Thiamine responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr. 2006;95:99–104.CrossRefPubMedGoogle Scholar
  7. 7.
    Onal H, Barış S, Özdil M, et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr. 2009;51:301–4.PubMedGoogle Scholar
  8. 8.
    Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Eur J Endocrinol. 2006;155:787–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Borgna-Pignatti C, Azzalli M, Pedretti S. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. J Pediatr. 2009;155:295–7.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2010

Authors and Affiliations

  • Ali Bay
    • 1
    • 6
  • Mehmet Keskin
    • 2
  • Samil Hizli
    • 3
  • Hatice Uygun
    • 4
  • Alper Dai
    • 4
  • Fatma Gumruk
    • 5
  1. 1.Department of Pediatrics, Division of Pediatric HematologyGaziantep UniversityGaziantepTurkey
  2. 2.Department of Pediatrics, Division of Pediatric EndocrinologyGaziantep UniversityGaziantepTurkey
  3. 3.Department of Pediatrics, Division of Pediatric GastroenterologyGaziantep UniversityGaziantepTurkey
  4. 4.Department of PediatricsGaziantep UniversityGaziantepTurkey
  5. 5.Department of Pediatrics, Division of Pediatric HematologyHacettepe UniversityAnkaraTurkey
  6. 6.Gaziantep Universitesi Tıp Fakultesi Cocuk Hastalıkları KlinigiGaziantepTurkey

Personalised recommendations